Plain-English translation of NCT07427511 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
SwissNeuroRehab is testing a high-dose, high-intensity rehabilitation program that uses digital devices to help stroke survivors regain movement and function. Rather than standard rehabilitation alone, participants in this study will receive about 5 hours per week of active, technology-supported training tailored to their individual needs across different care settings—hospital, clinic, and home.
Stroke can cause serious loss of movement and function, and standard rehabilitation may not provide enough intensive practice to maximize recovery. This study wants to see whether a more intensive, technology-supported approach can help stroke survivors recover better function and whether it's practical to deliver across different healthcare settings in Switzerland.
You likely qualify if…
You likely don't qualify if…
You would participate in an intensive rehabilitation program that lasts up to 12–15 months, receiving about 5 hours per week of active training with digital therapeutic devices. This training would happen across three settings as you progress: in the hospital, in an outpatient clinic, and at home. You would also complete assessments (physical tests, questionnaires, and surveys) at the beginning of the program, at the end, and at follow-up visits to measure your progress and track your recovery.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Switzerland